Prothrombin time

Prothrombin time (PT) is a blood test that measures the time it takes for a clot to form in a blood sample after certain clotting factors have been added. It is primarily used to evaluate the extrinsic and common pathways of the coagulation cascade, and is particularly important in monitoring the effectiveness of anticoagulant therapy, such as with warfarin.<ref>Tripodi, A,

 The laboratory and the direct oral anticoagulants, 
 Blood, 
 2013,
 
 
 DOI: 10.1182/blood-2012-11-459865,
 PMID: 23335186,</ref>

Coagulometer

Procedure and Interpretation

The prothrombin time test is performed on a sample of a patient's blood. This sample is mixed with a substance called tissue factor (also known as thromboplastin), which initiates the clotting process. The time taken for the blood to clot is then measured and reported as the prothrombin time. The result is often expressed relative to the control sample, in a value known as the international normalized ratio (INR).<ref>JV,

 Practical Haematology, 
  
 Elsevier, 
 2012, 
  
  
 ISBN 978-0702051479,</ref>

The normal range for PT varies from laboratory to laboratory but is generally around 11 to 14 seconds. A prolonged PT indicates a deficiency in the factors of the extrinsic or common coagulation pathways, or the presence of an inhibitor. If a patient is on anticoagulant therapy, a longer PT is expected and indicates the effectiveness of the treatment.<ref>Keeling, D,

 Guidelines on oral anticoagulation with warfarin - fourth edition, 
 British Journal of Haematology, 
 2011,
 
 
 DOI: 10.1111/j.1365-2141.2011.08753.x,
 PMID: 21671894,</ref>

Clinical Use

Prothrombin time is used in various clinical situations:

• Monitoring patients on warfarin therapy
• Evaluating the cause of unexplained bleeding or bruising
• Checking for low levels of clotting factors
• Assessing liver damage, as the liver produces clotting factors<ref>Northup, PG,

 Coagulation in liver disease: a guide for the clinician, 
 Clinical Gastroenterology and Hepatology, 
 2013,
 
 
 DOI: 10.1016/j.cgh.2013.02.014,
 PMID: 23419359,</ref>

Limitations and Challenges

While PT is a valuable tool in assessing clotting function, it has some limitations. The test only measures the function of certain clotting factors, so it may be normal even when a person has a bleeding disorder. Other tests, like activated partial thromboplastin time (aPTT), may be used in conjunction with PT for a more comprehensive evaluation of a patient's coagulation system.<ref>Cuker, A,

 Coagulopathy testing in patients with acute ischemic stroke, 
 Stroke, 
 2011,
 
 
 DOI: 10.1161/STROKEAHA.111.626853,
 PMID: 21940965,</ref>

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia